These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3940542)

  • 21. Platelet activation induces increased Fc gamma receptor expression.
    McCrae KR; Shattil SJ; Cines DB
    J Immunol; 1990 May; 144(10):3920-7. PubMed ID: 2139675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics of the binding of platelet-activating factor to platelets of different animal species.
    Iñarrea P; Gomez-Cambronero J; Nieto M; Crespo MS
    Eur J Pharmacol; 1984 Oct; 105(3-4):309-15. PubMed ID: 6510472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The calcium-dependent neutral protease of human blood platelets: a comparison of its effects on the receptors for von Willebrand factor and for the Fc-fragment derived from IgG.
    Spycher MO; Nydegger UE; Luescher EF
    Adv Exp Med Biol; 1984; 167():241-51. PubMed ID: 6324552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human platelet activation by bacterial phospholipase C: mechanism of inhibition by flurazepam.
    Anwer K; Wallace D; Romstedt K; Huzoor-Akbar
    Thromb Res; 1988 Jan; 49(2):225-39. PubMed ID: 2896397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of wheat germ agglutinin with human platelets: a model for studying platelet response.
    Rendu F; Lebret M
    Thromb Res; 1984 Dec; 36(5):447-56. PubMed ID: 6441308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uptake of radiolabeled and colloidal gold-labeled chyle chylomicrons and chylomicron remnants by rat platelets in vitro.
    Xu N; Zhou L; Odselius R; Nilsson A
    Arterioscler Thromb Vasc Biol; 1995 Jul; 15(7):972-81. PubMed ID: 7541295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intralipid rapidly attenuates the agonist-induced activation of rat platelets in vitro.
    Zhou L; Xu N; Nilsson A
    Thromb Res; 1997 Jan; 85(1):53-62. PubMed ID: 8983125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of sodium periodate on platelet functions.
    Cazenave JP; Reimers HJ; Kinlough-Rathbone RL; Packham MA; Mustard JF
    Lab Invest; 1976 May; 34(5):471-81. PubMed ID: 178961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Staphylococci-induced human platelet injury mediated by protein A and immunoglobulin G Fc fragment receptor.
    Hawiger J; Steckley S; Hammond D; Cheng C; Timmons S; Glick AD; Des Prez RM
    J Clin Invest; 1979 Oct; 64(4):931-7. PubMed ID: 479376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of [3H]forskolin binding to human platelet membranes by GppNHp, NaF, and prostaglandin E1.
    Nelson CA; Seamon KB
    FEBS Lett; 1985 Apr; 183(2):349-52. PubMed ID: 4039272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Observations on the effects of cytochalasin B and cytochalasin D on ADP- and chymotrypsin-treated platelets.
    Peerschke EI
    Proc Soc Exp Biol Med; 1984 Jan; 175(1):109-15. PubMed ID: 6694966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet aggregation by isolated and aggregated human IgG.
    Palosuo T; Leikola J
    Clin Exp Immunol; 1975 May; 20(2):371-4. PubMed ID: 1212812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxidized LDL decreases L-arginine uptake and nitric oxide synthase protein expression in human platelets: relevance of the effect of oxidized LDL on platelet function.
    Chen LY; Mehta P; Mehta JL
    Circulation; 1996 May; 93(9):1740-6. PubMed ID: 8653881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Irreversible loss of [3H]forskolin binding sites in human platelets by alpha-haloacetyl analogs of forskolin.
    Laurenza A; Morris D; Seamon KB
    Mol Pharmacol; 1990 Jan; 37(1):69-74. PubMed ID: 2153911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of cathepsin G pretreatment of platelets on their subsequent responses to aggregating agents.
    Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA
    Thromb Res; 1999 Sep; 95(6):315-23. PubMed ID: 10527409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hydrogen peroxide and methyl mercury are primary stimuli of eicosanoid release in human platelets.
    Hornberger W; Patscheke H
    J Clin Chem Clin Biochem; 1989 Sep; 27(9):567-75. PubMed ID: 2481709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Binding of [3H]SR 27417, a novel platelet-activating factor (PAF) receptor antagonist, to rabbit and human platelets and polymorphonuclear leukocytes.
    Herbert JM; Laplace MC; Maffrand JP
    Biochem Pharmacol; 1993 Jan; 45(1):51-8. PubMed ID: 8381007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effet of prostaglandin E1 alone and in combination with theophylline or aspirin on collagen-induced platelet aggregation and on platelet nucleotides including adenosine 3':5'-cyclic monophosphate.
    Ball G; Brereton GG; Fulwood M; Ireland DM; Yates P
    Biochem J; 1970 Dec; 120(4):709-18. PubMed ID: 4322038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relationship between shape change and release reaction of lectin-stimulated platelets. Effects of cytochalasin B and prostaglandin E1.
    Patscheke H; Wörner P; Brossmer R
    Thromb Res; 1977 Mar; 10(3):465-74. PubMed ID: 854880
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.